Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research on breast cancer detailed by S.H. Giordano and co-authors
July 17th, 2008
According to a study from the United States, "I. v. bisphosphonates reduce skeletal events in women with bone metastases from breast cancer, but little is known about the prevalence and duration of bisphosphonate use. Patients were identified from the Surveillance, Epidemiology, and End Results-Medicare database who were aged >= 65 years and were diagnosed with invasive breast cancer in 1995-2002." "Healthcare Common Procedure Coding System codes were used to identify patients treated with pamidronate and zoledronic acid. Descriptive statistics were used to describe patterns of use. Multivariate analyses were performed to determine the predictors of bisphosphonate...
Source: Women's Health Weekly (2008-07-17)
|
